Blood-based biomarkers for mucopolysaccharidosis type I and IIIMolecular Genetics and MetabolismIF3.52026-02-030PRE
Neurofilament light chain as a prognostic marker in cerebral adrenoleukodystrophy神经丝轻链作为肾上腺脑白质营养不良的预后标志物BrainIF11.72025-09-240OAAI
Outcome of Haemopoietic Stem Cell Transplantation in 21 Patients With Alpha-Mannosidosisα-甘露糖苷症21例患者的造血干细胞移植结局Journal of Inherited Metabolic DiseaseIF3.82025-06-230PRE
Changes in CSF GAG after intravenous enzyme replacement therapyMOLECULAR GENETICS AND METABOLISMIF3.52025-02-010PRE
Long term enzyme replacement therapy after hematopoietic stemcell transplant results in immune tolerance and improvedbiochemical outcomesMOLECULAR GENETICS AND METABOLISMIF3.52025-02-010PRE
Phenotype differentiation and white matter preservation by early hematopoietic cell transplantation - Free-water diffusion tensor MRI study of the brain in mucopolysaccharidosis type I patientsMOLECULAR GENETICS AND METABOLISMIF3.52025-02-010PRE
Targeted therapeutic benefits of anakinra for sleep, gastrointestinal, and behavioral symptoms in Sanfilippo syndrome: A post hoc analysis in symptom-specific subgroupsMOLECULAR GENETICS AND METABOLISMIF3.52025-02-010PRE
CSF GAG reduction is associated with a decrease in inflammationMOLECULAR GENETICS AND METABOLISMIF3.52025-02-010PRE
Heparan sulfate reduction in cerebrospinal fluid is associated with long-term cognitive outcomes in Hurler syndromeMOLECULAR GENETICS AND METABOLISMIF3.52025-02-010PRE
Outcome of hematopoietic stem cell transplantation in 19 patients with alpha-mannosidosisMOLECULAR GENETICS AND METABOLISMIF3.52025-02-010PRE
Bone marrow transplantation reverses metabolic alterations in multiple sulfatase deficiency: a case seriesCOMMUNICATIONS MEDICINEIF6.32025-01-090OA
Anakinra in Sanfilippo syndrome: a phase 1/2 trial (Jul, 10.1038/s41591-024-03079-3, 2024)NATURE MEDICINEIF502024-07-290OAAI
Analysis of caregiver perspectives on patients with mucopolysaccharidosis II treated with pabinafusp alfa: results of qualitative interviews in JapanORPHANET JOURNAL OF RARE DISEASESIF3.52024-03-072OAAI
New blood-based biomarkers for Sanfilippo syndromeMOLECULAR GENETICS AND METABOLISMIF3.52024-02-010PRE
Ability change across multiple domains in mucopolysaccharidosis (Sanfilippo syndrome) type IIIAMOLECULAR GENETICS AND METABOLISMIF3.52024-02-012PRE
Enzyme replacement is associated with better long-term cognitive outcomes in Hurler syndromeMOLECULAR GENETICS AND METABOLISMIF3.52024-02-010PRE
Compassionate use of lentiviral gene therapy for metachromatic leukodystrophyMOLECULAR GENETICS AND METABOLISMIF3.52024-02-010PRE
Changes in CSF GAG after intravenous enzyme replacement therapyMOLECULAR GENETICS AND METABOLISMIF3.52024-02-010PRE
Transitioning from pediatric to adult health care in lysosomal diseases: The MPS experienceMOLECULAR GENETICS AND METABOLISMIF3.52024-02-010PRE